-+ 0.00%
-+ 0.00%
-+ 0.00%

ADDEX THERAPEUTICS - NEUROSTERIX COMPLETES PHASE 1 STUDIES OF NTX-253, PLANS PHASE 2 DEVELOPMENT

路透·10/08/2026 05:01:21

请登录查看新闻详情